Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Cash from Investing Activities (2019 - 2025)

Silo Pharma's Cash from Investing Activities history spans 7 years, with the latest figure at -$95474.0 for Q3 2025.

  • For Q3 2025, Cash from Investing Activities fell 136.13% year-over-year to -$95474.0; the TTM value through Sep 2025 reached $1.1 million, down 79.3%, while the annual FY2024 figure was $973777.0, 123.48% up from the prior year.
  • Cash from Investing Activities for Q3 2025 was -$95474.0 at Silo Pharma, down from $388102.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $6.8 million in Q3 2021 and bottomed at -$6.0 million in Q1 2023.
  • The 5-year median for Cash from Investing Activities is $66707.0 (2022), against an average of $309994.8.
  • The largest annual shift saw Cash from Investing Activities surged 135371.4% in 2021 before it crashed 30141.7% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at $349456.0 in 2021, then tumbled by 80.91% to $66707.0 in 2022, then soared by 6539.34% to $4.4 million in 2023, then tumbled by 100.85% to -$37659.0 in 2024, then plummeted by 153.52% to -$95474.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Cash from Investing Activities are -$95474.0 (Q3 2025), $388102.0 (Q2 2025), and $871381.0 (Q1 2025).